CLINICAL_TRIALS
trial_result
· 2023-04-26
Clinical Trial Update: A Placebo-controlled Phase 2 Trial to Investigate the Safety and Efficacy of Secukinumab in Giant Cell Arteritis [Phase 2]
Summary
Phase 2 trial evaluating safety and efficacy of secukinumab in Giant Cell Arteritis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Giant Cell Arteritis | Phase 2 | Status: COMPLETED | Results posted: 2023-04-26